You are here » Home » Companies » Aarti Drugs Ltd - Announcements

Aarti Drugs Ltd.

BSE: 524348 Sector: Health care
NSE: AARTIDRUGS ISIN Code: INE767A01016
BSE 00:00 | 18 Oct 455.95 7.10
(1.58%)
OPEN

451.00

HIGH

456.25

LOW

448.00

NSE 00:00 | 18 Oct 456.00 7.15
(1.59%)
OPEN

448.00

HIGH

456.45

LOW

447.85

Outcome Of Board Meeting Held Today I.E. Wednesday May 15 2019 Pursuant To Regulation 33 And Regulat

May 15, 2019, 3:00 pm | Source: BSE | Downlaod PDFDownload PDF

Pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we inform you that the Board of Directors at its Meeting held today i.e. Wednesday May 15 2019 had inter-alia considered and approved the following:-

a)Statement of Audited Financial Results (Standalone & Consolidated) for the Quarter & year ended March 31 2019 (attached);

b)The Audit Report(s) by M/s. Kirtane & Pandit LLP Chartered Accountants the Statutory Auditors of the Company on the Standalone and Consolidated Financial Results for the quarter and year ended March 31 2019 along with the declaration in respect of Audit Report(s) with unmodified opinion for the Financial Year ended on March 31 2019 (attached);

c)Recommended the Final Dividend @ Rs. 1/-(Rupee One) i.e. (10%) per share of Rs. 10/- each for the Financial year ended 2018-2019.